Lancet Methodological-Statistical Series
http://www.thelancet.com/collections/series/epidemiology
Sample size
calculations in randomised trials: mandatory and mystical. Kenneth F Schulz,
David A Grimes
- 9 April 2005
(Vol. 365, Issue 9467, pages 1348-1353)
Summary |
Full Text
Compared to what? Finding
controls for case-control studies. David A Grimes,
Kenneth F Schulz
- 16 April 2005
(Vol. 365, Issue 9468, pages 1429-1433)
Summary |
Full Text
Refining clinical
diagnosis with likelihood ratios. David A Grimes,
Kenneth F Schulz
- 23 April 2005
(Vol. 365, Issue 9469, pages 1500-1505)
Summary |
Full Text
Multiplicity in randomised
trials I: endpoints and treatments. Kenneth F Schulz,
David A Grimes
- 30 April 2005
(Vol. 365, Issue 9470, pages 1591-1595)
Summary |
Full Text
Multiplicity
in randomised trials II: subgroup and interim analyses.
Kenneth F Schulz, David A Grimes
- 7 May 2005
(Vol. 365, Issue 9471, pages 1657-1661)
Summary |
Full Text
Evidence-based practice and the individual. Summerskill W - 01 January 2005 (Vol. 365, Issue 9453, pages 13-14). Full Text
External validity of randomised controlled trials: “To whom do the results of this trial apply?”. Rothwell PM - 01 January 2005 (Vol. 365, Issue 9453, pages 82-93) Summary | Full Text
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Rothwell PM - 08 January 2005 (Vol. 365, Issue 9454, pages 176-186) Summary | Full Text
From subgroups to individuals: general principles and the example of carotid endarterectomy. Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP - 15 January 2005 (Vol. 365, Issue 9455, pages 256-265). Summary | Full Text
Can meta-analysis help target interventions at individuals most likely to benefit?. Thompson SG, Higgins JP - 22 January 2005 (Vol. 365, Issue 9456, pages 341-346). Summary | Full Text
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A - 29 January 2005 (Vol. 365, Issue 9457, pages 434-441). Summary | Full Text
2002
Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359(9306):614-618 [Full text PDF].
Schulz KF, Grimes DA.
Blinding in randomised trials: hiding who got what.
Lancet
2002;359(9307):696-700
[Summary].
Schulz KF, Grimes DA.
Case-control studies: research in reverse.
Lancet
2002;359(9304):431-434
[Summary].
Grimes DA, Schulz KF.
Cohort studies: marching towards outcomes.
Lancet
2002;359(9303):341-345
[Full Text PDF].
Grimes DA, Schulz KF.
Descriptive studies: what they can and cannot do.
Lancet
2002;359(9301):145-149
[Summary].
Schulz KF, Grimes DA.
Generation of allocation sequences in randomised trials: chance, not
choice.
Lancet
2002;359(9305):515-519
[Summary].
Grimes DA, Schulz KF.
An overview of clinical research: the lay of the land.
Lancet
2002;359(9300):57-61
[Full Text PDF].
Schulz KF, Grimes DA.
Sample size slippages in randomised trials: exclusions and the lost and
wayward.
Lancet
2002;359(9308):781-785
[Summary].
Schulz KF, Grimes DA.
Unequal group sizes in randomised trials: guarding against guessing.
Lancet
2002;359(9310):966-970
[Summary].
Grimes DA, Schulz KF.
Uses and abuses of screening tests.
Lancet
2002;359(9309):881-884
[Summary].
Sass JO, Pascoe-González S, Lehnert W, Grimes D, Schulz K.
Screening in clinical trials [letters].
Lancet
2002;360(9337):952
[Full Text].
Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002;359(9302):248-252 [Summary].
2005
Sample size calculations in randomised trials: mandatory and mystical. Schulz KF, Grimes DA - 09 April 2005 (Vol. 365, Issue 9467, pages 1348-1353). Summary | Full Text
Compared to what? Finding controls for case-control studies. Grimes DA, Schulz KF - 16 April 2005 (Vol. 365, Issue 9468, pages 1429-1433). Summary | Full Text
Refining clinical diagnosis with likelihood ratios. Grimes DA, Schulz KF - 23 April 2005 (Vol. 365, Issue 9469, pages 1500-1505). Summary | Full Text
Multiplicity in randomised trials I: endpoints and treatments. Schulz KF, Grimes DA - 30 April 2005 (Vol. 365, Issue 9470, pages 1591-1595). Summary | Full Text
Multiplicity in randomised trials II: subgroup and interim analyses. Schulz KF, Grimes DA - 07 May 2005 (Vol. 365, Issue 9471, pages 1657-1661). Summary | Full Text
Genetic epidemiology and public health: hope, hype, and future prospects. Smith GD, Ebrahim S, Lewis S, Hansell AL, Palmer LJ, Burton PR - 22 October 2005 (Vol. 366, Issue 9495, pages 1484-1498). Summary | Full Text
Population-based family studies in genetic epidemiology. Hopper JL, Bishop DT, Easton DF - 15 October 2005 (Vol. 366, Issue 9494, pages 1397-1406. Summary | Full Text
What makes a good genetic association study?. Hattersley AT, McCarthy MI - 08 October 2005 (Vol. 366, Issue 9493, pages 1315-1323). Summary | Full Text
Shaking the tree: mapping complex disease genes with linkage disequilibrium. Palmer LJ, Cardon LR - 01 October 2005 (Vol. 366, Issue 9492, pages 1223-1234). Summary | Full Text
Genetic association studies. Cordell HJ, Clayton DG - 24 September 2005 (Vol. 366, Issue 9491, pages 1121-1131). Summary | Full Text
Genetic linkage studies. Dawn Teare M, Barrett JH - 17 September 2005 (Vol. 366, Issue 9490, pages 1036-1044). Summary | Full Text
Key concepts in genetic epidemiology. Burton PR, Tobin MD, Hopper JL - 10 September 2005 (Vol. 366, Issue 9489, pages 941-951). Summary | Full Text
Otros:
Horton R. From star signs to trial guidelines. Lancet 2000; 355: 1033–34.
Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other mis(uses) of baseline data in clinical trials. Lancet 2000; 255: 1064-1069.